Danville, Pa.-based Geisinger plans to extend its genomics efforts beyond research and into routine clinical care, Geisinger President and CEO David T. Feinberg, MD, announced May 6 during the HLTH ...
Whole genome sequencing (WGS) is not necessarily a solution for someone with a rare, monogenic disease. Indeed, more than half of families with suspected rare monogenic diseases do not have an answer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results